![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Beher Dirk Graham Samuel L
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.14, Iss.11, 2005-11, pp. : 1385-1409
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease
By McGeer P.L.
Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. :